These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1067 related articles for article (PubMed ID: 9217715)

  • 1. Serious reactions after mass treatment of onchocerciasis with ivermectin in an area endemic for Loa loa infection.
    Gardon J; Gardon-Wendel N; Demanga-Ngangue ; Kamgno J; Chippaux JP; Boussinesq M
    Lancet; 1997 Jul; 350(9070):18-22. PubMed ID: 9217715
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Implications for annual retesting after a test-and-not-treat strategy for onchocerciasis elimination in areas co-endemic with Loa loa infection: an observational cohort study.
    Pion SD; Nana-Djeunga H; Niamsi-Emalio Y; Chesnais CB; Deléglise H; Mackenzie C; Stolk W; Fletcher DA; Klion AD; Nutman TB; Boussinesq M; Kamgno J
    Lancet Infect Dis; 2020 Jan; 20(1):102-109. PubMed ID: 31676244
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Relationships between the prevalence and intensity of Loa loa infection in the Central province of Cameroon.
    Boussinesq M; Gardon J; Kamgno J; Pion SD; Gardon-Wendel N; Chippaux JP
    Ann Trop Med Parasitol; 2001 Jul; 95(5):495-507. PubMed ID: 11487371
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A Test-and-Not-Treat Strategy for Onchocerciasis in Loa loa-Endemic Areas.
    Kamgno J; Pion SD; Chesnais CB; Bakalar MH; D'Ambrosio MV; Mackenzie CD; Nana-Djeunga HC; Gounoue-Kamkumo R; Njitchouang GR; Nwane P; Tchatchueng-Mbouga JB; Wanji S; Stolk WA; Fletcher DA; Klion AD; Nutman TB; Boussinesq M
    N Engl J Med; 2017 Nov; 377(21):2044-2052. PubMed ID: 29116890
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Structure of the microfilarial reservoir of Loa loa in the human host and its implications for monitoring the progr,ammes of Community-Directed Treatment with Ivermectin carried out in Africa.
    Pion DS; Gardon J; Kamgno J; Gardon-Wendel N; Chippaux JP; Boussinesq M
    Parasitology; 2004 Nov; 129(Pt 5):613-26. PubMed ID: 15552406
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Three probable cases of Loa loa encephalopathy following ivermectin treatment for onchocerciasis.
    Boussinesq M; Gardon J; Gardon-Wendel N; Kamgno J; Ngoumou P; Chippaux JP
    Am J Trop Med Hyg; 1998 Apr; 58(4):461-9. PubMed ID: 9574793
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Satellite mapping of Loa loa prevalence in relation to ivermectin use in west and central Africa.
    Thomson MC; Obsomer V; Dunne M; Connor SJ; Molyneux DH
    Lancet; 2000 Sep; 356(9235):1077-8. PubMed ID: 11009145
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Co-endemicity of loiasis and onchocerciasis in rain forest communities in southwestern Nigeria.
    Ojurongbe O; Akindele AA; Adeleke MA; Oyedeji MO; Adedokun SA; Ojo JF; Akinleye CA; Bolaji OS; Adefioye OA; Adeyeba OA
    PLoS Negl Trop Dis; 2015 Mar; 9(3):e0003633. PubMed ID: 25812086
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Secondary effects of the treatment of hypermicrofilaremic loiasis using ivermectin].
    Ducorps M; Gardon-Wendel N; Ranque S; Ndong W; Boussinesq M; Gardon J; Schneider D; Chippaux JP
    Bull Soc Pathol Exot; 1995; 88(3):105-12. PubMed ID: 8555762
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Macrofilaricidal activity after doxycycline only treatment of Onchocerca volvulus in an area of Loa loa co-endemicity: a randomized controlled trial.
    Turner JD; Tendongfor N; Esum M; Johnston KL; Langley RS; Ford L; Faragher B; Specht S; Mand S; Hoerauf A; Enyong P; Wanji S; Taylor MJ
    PLoS Negl Trop Dis; 2010 Apr; 4(4):e660. PubMed ID: 20405054
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impact of repeated annual community directed treatment with ivermectin on loiasis parasitological indicators in Cameroon: Implications for onchocerciasis and lymphatic filariasis elimination in areas co-endemic with Loa loa in Africa.
    Wanji S; Chounna Ndongmo WP; Fombad FF; Kengne-Ouafo JA; Njouendou AJ; Longang Tchounkeu YF; Koudou B; Bockarie M; Fobi G; Roungou JB; Enyong PA
    PLoS Negl Trop Dis; 2018 Sep; 12(9):e0006750. PubMed ID: 30226900
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Rapid assessment method for prevalence and intensity of Loa loa infection.
    Takougang I; Meremikwu M; Wandji S; Yenshu EV; Aripko B; Lamlenn SB; Eka BL; Enyong P; Meli J; Kale O; Remme JH
    Bull World Health Organ; 2002; 80(11):852-8. PubMed ID: 12481206
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Co-infection with Onchocerca volvulus and Loa loa microfilariae in central Cameroon: are these two species interacting?
    Pion SD; Clarke P; Filipe JA; Kamgno J; Gardon J; Basáñez MG; Boussinesq M
    Parasitology; 2006 Jun; 132(Pt 6):843-54. PubMed ID: 16469200
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ocular findings after ivermectin treatment of patients with high Loa loa microfilaremia.
    Fobi G; Gardon J; Santiago M; Ngangue D; Gardon-Wendel N; Boussinesq M
    Ophthalmic Epidemiol; 2000 Mar; 7(1):27-39. PubMed ID: 10652169
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Integrated rapid mapping of onchocerciasis and loiasis in the Democratic Republic of Congo: impact on control strategies.
    Tekle AH; Zoure H; Wanji S; Leak S; Noma M; Remme JH; Amazigo U
    Acta Trop; 2011 Sep; 120 Suppl 1():S81-90. PubMed ID: 20525531
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prevalences of Loa loa microfilaraemia throughout the area endemic for the infection.
    Boussinesq M; Gardon J
    Ann Trop Med Parasitol; 1997 Sep; 91(6):573-89. PubMed ID: 9425360
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Epidemiology of concomitant infections due to Loa loa, Mansonella perstans, and Onchocerca volvulus in rain forest villages of Cameroon.
    Wanji S; Tendongfor N; Esum M; Ndindeng S; Enyong P
    Med Microbiol Immunol; 2003 Feb; 192(1):15-21. PubMed ID: 12592559
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Co-endemicity of loiasis and onchocerciasis in the South West Province of Cameroon: implications for mass treatment with ivermectin.
    Esum M; Wanji S; Tendongfor N; Enyong P
    Trans R Soc Trop Med Hyg; 2001; 95(6):673-6. PubMed ID: 11816443
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Analysis of the prevention of post-ivermectin Loa loa encephalopathy by administration of initial low dose].
    Kamgno J; Gardon J; Boussinesq M
    Med Trop (Mars); 2000; 60(3):275-7. PubMed ID: 11258063
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Single dose moxidectin versus ivermectin for Onchocerca volvulus infection in Ghana, Liberia, and the Democratic Republic of the Congo: a randomised, controlled, double-blind phase 3 trial.
    Opoku NO; Bakajika DK; Kanza EM; Howard H; Mambandu GL; Nyathirombo A; Nigo MM; Kasonia K; Masembe SL; Mumbere M; Kataliko K; Larbelee JP; Kpawor M; Bolay KM; Bolay F; Asare S; Attah SK; Olipoh G; Vaillant M; Halleux CM; Kuesel AC
    Lancet; 2018 Oct; 392(10154):1207-1216. PubMed ID: 29361335
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 54.